Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1968 1
1969 1
1970 1
1971 1
1972 10
1973 3
1974 2
1975 1
1976 1
1978 1
1979 2
1980 1
1984 2
1987 3
1988 1
1989 1
1990 4
1991 6
1992 12
1993 10
1994 11
1995 15
1996 7
1997 12
1998 11
1999 6
2000 17
2001 18
2002 22
2003 17
2004 30
2005 25
2006 21
2007 27
2008 22
2009 20
2010 20
2011 16
2012 17
2013 24
2014 18
2015 26
2016 20
2017 19
2018 21
2019 30
2020 21
2021 19
2022 13
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

580 results

Results by year

Filters applied: . Clear all
Page 1
Migraine.
Silberstein SD. Silberstein SD. Lancet. 2004 Jan 31;363(9406):381-91. doi: 10.1016/S0140-6736(04)15440-8. Lancet. 2004. PMID: 15070571 Review.
Preventive Migraine Treatment.
Silberstein SD. Silberstein SD. Continuum (Minneap Minn). 2015 Aug;21(4 Headache):973-89. doi: 10.1212/CON.0000000000000199. Continuum (Minneap Minn). 2015. PMID: 26252585 Free PMC article. Review.
Pathophysiology, prevention, and treatment of medication overuse headache.
Diener HC, Dodick D, Evers S, Holle D, Jensen RH, Lipton RB, Porreca F, Silberstein S, Schwedt T. Diener HC, et al. Among authors: silberstein s. Lancet Neurol. 2019 Sep;18(9):891-902. doi: 10.1016/S1474-4422(19)30146-2. Epub 2019 Jun 4. Lancet Neurol. 2019. PMID: 31174999 Review.
Neuropeptides.
Silberstein SD. Silberstein SD. Headache. 2017 May;57 Suppl 2:35-36. doi: 10.1111/head.13093. Headache. 2017. PMID: 28485847 No abstract available.
Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.
Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Silberstein SD, et al. Neurology. 2012 Apr 24;78(17):1337-45. doi: 10.1212/WNL.0b013e3182535d20. Neurology. 2012. PMID: 22529202 Free PMC article. Review.
Fremanezumab for the Preventive Treatment of Chronic Migraine.
Silberstein SD, Dodick DW, Bigal ME, Yeung PP, Goadsby PJ, Blankenbiller T, Grozinski-Wolff M, Yang R, Ma Y, Aycardi E. Silberstein SD, et al. N Engl J Med. 2017 Nov 30;377(22):2113-2122. doi: 10.1056/NEJMoa1709038. N Engl J Med. 2017. PMID: 29171818 Free article. Clinical Trial.
580 results